A single reaction-diffusion equation for the multifarious eruptions of urticaria
暂无分享,去创建一个
Sungrim Seirin-Lee | Yuhki Yanase | Michihiro Hide | Shunsuke Takahagi | Y. Yanase | M. Hide | S. Seirin-Lee | S. Takahagi
[1] M. Hide,et al. Impact of chronic urticaria on quality of life and work in Japan: Results of a real‐world study , 2018, The Journal of dermatology.
[2] Y. Matsuo,et al. The role of adenosine for IgE receptor-dependent degranulation of human peripheral basophils and skin mast cells. , 2018, Allergology international : official journal of the Japanese Society of Allergology.
[3] Y. Yanase,et al. Chronic spontaneous urticaria and the extrinsic coagulation system. , 2017, Allergology international : official journal of the Japanese Society of Allergology.
[4] H. Kiyono,et al. New era for mucosal mast cells: their roles in inflammation, allergic immune responses and adjuvant development , 2014, Experimental & Molecular Medicine.
[5] M. Steinhoff,et al. Mast cells are critical for the limitation of thrombin‐induced skin inflammation , 2018, Experimental dermatology.
[6] Y. Matsuo,et al. Neuromedin U directly induces degranulation of skin mast cells, presumably via MRGPRX2 , 2018, Allergy.
[7] L. Petersen,et al. Histamine is released in the wheal but not the flare following challenge of human skin in vivo: a microdialysis study , 1997, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[8] Hua Xie,et al. Activation of human tonsil and skin mast cells by agonists of proteinase activated receptor‐2 , 2005, Acta Pharmacologica Sinica.
[9] Y. Okayama,et al. Significantly High Levels of Anti-dsDNA Immunoglobulin E in Sera and the Ability of dsDNA to Induce the Degranulation of Basophils from Chronic Urticaria Patients , 2013, International Archives of Allergy and Immunology.
[10] Ayaka Tanaka,et al. Efficacy of increased dose of rupatadine up to 20 mg on itching in Japanese patients due to chronic spontaneous urticaria, dermatitis, or pruritus: A post hoc analysis of phase III clinical trial , 2019, Journal of Cutaneous Immunology and Allergy.
[11] R. Dellavalle,et al. Global burden of urticaria: Insights from the 2016 Global Burden of Disease Study , 2018, Journal of the American Academy of Dermatology.
[12] A. Bossios,et al. New biological treatments for asthma and skin allergies , 2019, Allergy.
[13] Yasuaki Kobayashi,et al. Mathematical model for calcium-assisted epidermal homeostasis. , 2016, Journal of theoretical biology.
[14] R. Singer,et al. Management of chronic inducible urticaria according to the guidelines: A prospective controlled study. , 2017, Journal of dermatological science.
[15] A. Marzano,et al. Detection of Low-Molecular-Weight Mast Cell-Activating Factors in Serum From Patients With Chronic Spontaneous Urticaria. , 2016, Journal of investigational allergology & clinical immunology.
[16] O. Schmetzer,et al. IL‐24 is a common and specific autoantigen of IgE in patients with chronic spontaneous urticaria , 2017, The Journal of allergy and clinical immunology.
[17] R. Fantozzi,et al. The role of histamine in neurogenic inflammation , 2013, British journal of pharmacology.
[18] Y. Yanase,et al. Histamine and Toll-like receptor ligands synergistically induce endothelial cell gap formation by the extrinsic coagulating pathway. , 2017, The Journal of allergy and clinical immunology.
[19] A. Kaplan,et al. Assessment of tissue fluid histamine levels in patients with urticaria. , 1978, The Journal of allergy and clinical immunology.
[20] J. Kochan,et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. , 1993, The New England journal of medicine.
[21] Young-Ho Jung,et al. Prevalence and Risk Factors of Urticaria With a Focus on Chronic Urticaria in Children , 2017, Allergy, asthma & immunology research.
[22] Sanjiv K. Jain. Pathogenesis of Chronic Urticaria: An Overview , 2014, Dermatology research and practice.
[23] T. Casale,et al. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. , 2013, The New England journal of medicine.
[24] M. Maurer,et al. The role and relevance of mast cells in urticaria , 2018, Immunological reviews.
[25] J. Bousquet,et al. Unmet clinical needs in chronic spontaneous urticaria. A GA2LEN task force report 1 , 2011, Allergy.
[26] I. Barshack,et al. The Histopathology of Urticaria Revisited—Clinical Pathological Study , 2017, The American Journal of dermatopathology.
[27] B. Guida,et al. Histamine plasma levels and elimination diet in chronic idiopathic urticaria , 2000, European Journal of Clinical Nutrition.
[28] S. Saini,et al. Emerging Therapies in Chronic Spontaneous Urticaria , 2019, Allergy, asthma & immunology research.
[29] R. Seifert,et al. Histamine and Histamine Receptors in Health and Disease , 2017 .
[30] C. Grattan,et al. Management and diagnostic guidelines for urticaria and angio‐oedema , 2001, The British journal of dermatology.
[31] K. Kumon,et al. Diagnosis and long‐term management of hydrolyzed wheat protein wheat‐dependent exercise‐induced anaphylaxis , 2015, Acute medicine & surgery.
[32] J. Garssen,et al. Non-IgE mediated mast cell activation. , 2016, European journal of pharmacology.
[33] T. Zuberbier,et al. Definition, classification, and routine diagnosis of urticaria: a consensus report. , 2001, The journal of investigative dermatology. Symposium proceedings.
[34] M. Greaves. Pathology and classification of urticaria. , 2014, Immunology and allergy clinics of North America.
[35] M. Hide,et al. Food-dependent exercise-induced anaphylaxis due to ingestion of orange. , 2004, Acta dermato-venereologica.
[36] Z. Jaffar,et al. Histamine secretion from mast cells stimulated with ATP , 1990, Agents and Actions.